resveratrol has been researched along with Respiratory Distress Syndrome in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Hartmann, EK; Kamuf, J; Kirchner, L; Mohnke, K; Renz, M; Riedel, J; Rissel, R; Ruemmler, R; Ziebart, A | 1 |
Grebenchikov, OA; Zinovkin, RA | 1 |
Capuano, F; Frari, V; Greco, F; Micera, A; Salvinelli, F | 1 |
Alghetaa, H; Mohammed, A; Nagarkatti, M; Nagarkatti, P; Singh, N; Zhou, J | 1 |
Chen, T; Jin, F; Li, W; Liu, X; Ma, L; Nan, Y; Wang, R; Zhao, Y | 1 |
Kamholz, SL | 1 |
1 review(s) available for resveratrol and Respiratory Distress Syndrome
Article | Year |
---|---|
Wine, spirits and the lung: good, bad or indifferent?
Topics: Adenocarcinoma; Alcohol Drinking; Alcoholic Beverages; Alcoholism; Altitude Sickness; Antioxidants; Asthma; Female; Humans; Lung; Lung Neoplasms; Male; Pulmonary Disease, Chronic Obstructive; Pulmonary Edema; Respiratory Distress Syndrome; Resveratrol; Stilbenes; Sulfites; Wine | 2006 |
5 other study(ies) available for resveratrol and Respiratory Distress Syndrome
Article | Year |
---|---|
Resveratrol influences pulmonary mechanics and inflammatory response in a porcine ARDS model.
Topics: Animals; Anti-Inflammatory Agents; Lung; Respiratory Distress Syndrome; Resveratrol; Swine; Tumor Necrosis Factor-alpha | 2023 |
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
Topics: Animals; Antioxidants; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Dimethyl Fumarate; Female; Humans; Immunosuppressive Agents; Inflammation; Isothiocyanates; Male; Mice; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oxidative Stress; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Resveratrol; SARS-CoV-2; Signal Transduction; Sulfoxides; Thiosulfates | 2020 |
The potential role of trans-resveratrol/carboxymethylated (1.3/1.6)-β-d-glucan minimizing symptoms and improve healing after functional endoscopic sinus surgery.
Topics: Administration, Intranasal; Adult; Endoscopy; Female; Glucans; Humans; Male; Middle Aged; Nasal Mucosa; Postoperative Care; Respiratory Distress Syndrome; Resveratrol; Sinusitis; Young Adult | 2020 |
Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Colon; Cytokines; Disease Models, Animal; Dysbiosis; Enterotoxins; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Inflammation Mediators; Limosilactobacillus reuteri; Lung; Mice, Inbred C3H; Respiratory Distress Syndrome; Resveratrol; Superantigens | 2021 |
3,5,4'-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway.
Topics: Acetates; Animals; Capillary Permeability; Cells, Cultured; Inflammation Mediators; Lipopolysaccharides; Lung; Male; MAP Kinase Signaling System; Mice; Respiratory Distress Syndrome; Resveratrol; Sirtuin 1; Stilbenes | 2015 |